Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Short Interest Update

Rapid Micro Biosystems, Inc. (NASDAQ:RPID - Get Free Report) was the recipient of a large increase in short interest in the month of March. As of March 31st, there was short interest totalling 1,610,000 shares, an increase of 36.4% from the March 15th total of 1,180,000 shares. Based on an average daily volume of 522,000 shares, the short-interest ratio is presently 3.1 days. Approximately 7.9% of the company's shares are sold short.

Rapid Micro Biosystems Stock Up 0.4 %

Shares of NASDAQ:RPID traded up $0.01 during trading on Wednesday, hitting $2.31. The stock had a trading volume of 97,545 shares, compared to its average volume of 180,122. The company has a market capitalization of $99.88 million, a PE ratio of -2.06 and a beta of 1.12. The firm's fifty day moving average is $2.56 and its 200 day moving average is $1.72. Rapid Micro Biosystems has a 12 month low of $0.58 and a 12 month high of $4.04.

Rapid Micro Biosystems (NASDAQ:RPID - Get Free Report) last announced its quarterly earnings data on Friday, February 28th. The company reported ($0.22) EPS for the quarter, meeting the consensus estimate of ($0.22). The business had revenue of $8.22 million during the quarter, compared to analyst estimates of $8.20 million. Rapid Micro Biosystems had a negative return on equity of 48.05% and a negative net margin of 184.93%. Equities research analysts expect that Rapid Micro Biosystems will post -1.1 EPS for the current fiscal year.

Analysts Set New Price Targets

Separately, KeyCorp began coverage on shares of Rapid Micro Biosystems in a research report on Wednesday, February 12th. They set an "overweight" rating and a $8.00 price target on the stock.

Institutional Investors Weigh In On Rapid Micro Biosystems

Hedge funds and other institutional investors have recently bought and sold shares of the business. Millennium Management LLC boosted its position in shares of Rapid Micro Biosystems by 17.6% in the 4th quarter. Millennium Management LLC now owns 61,375 shares of the company's stock worth $55,000 after purchasing an additional 9,191 shares in the last quarter. Citadel Advisors LLC bought a new position in Rapid Micro Biosystems during the 4th quarter valued at approximately $65,000. Finally, Renaissance Technologies LLC raised its stake in Rapid Micro Biosystems by 122.9% during the fourth quarter. Renaissance Technologies LLC now owns 183,087 shares of the company's stock valued at $165,000 after buying an additional 100,942 shares during the last quarter. Hedge funds and other institutional investors own 52.60% of the company's stock.

Rapid Micro Biosystems Company Profile

Rapid Micro Biosystems, Inc, a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.